Appendix A - Audit Criteria
| Objective | Criteria |
|---|---|
| 1. Given the experimental nature of CMP as a treatment, has VAC implemented controls to mitigate the risk to Veterans’ health and well-being? | A. The 3g/day threshold is effective in limiting access to (i.e., reducing risk). |
| B. The exceptional process internal controls are effective in addressing heightened risk for this group of Veterans. | |
| C. Veterans are not reimbursed for more cannabis than for which they have been authorized. | |
| D. VAC monitors trends in usage (increased usage, linked conditions, mental health conditions, other drugs, contraindications) and takes action where warranted. | |
| E. VAC monitors trends in authorizations and takes action where warranted. | |
| F. VAC captures and monitors important data and trend (conditions treated, cannabis type, CBD/THC, methods of administration, etc.) to inform policy. | |
| 2. Given the exponential growth of demand for the CMP treatment benefit, has VAC established controls to mitigate the financial risk to VAC? | A. VAC monitors Cannabis spending for trends and forecasting. |
| B. VAC has recognized the growth in Cannabis spending and has devised mitigation strategies to address. | |
| C. VAC actively monitors the reasonableness and relevance of its $8.50/gram reimbursement rate. |
* The audit team confirmed that all of the above criteria were met unless otherwise stated in this audit report.